AstraZeneca shares hit all-time high after clinical trial
Positive results from a trial looking into the cardiovascular benefits of a diabetes drug have sent AstraZeneca shares flying to record highs.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: AstraZeneca | Cardiology | Cardiovascular | Clinical Trials | Diabetes | Endocrinology | Heart | Pharmaceuticals